Cell penetrating peptides for tumor targeting. 2011

Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
Department of Dental Regenerative Biotechnology, Dental Research Institute and School of Dentistry, Seoul National University, 28-2 Yongon-Dong, Chongno-Ku, Seoul 110-749, South Korea.

Anticancer drug delivery has been hindered due to cell membrane permeability and the lack of a selective marker for tumor cells. Cell permeability is related to the bioavailability of drugs and has therefore been considered to be an essential step for achieving therapeutic efficacy. While different types of transporters currently exist, cell penetrating peptides (CPPs) have become one of the most popular and effective tools for intracellular drug delivery. Most of the original CPPs are short peptides with basic residues. The mechanism of CPP cell entry remains to be established; however, the CPPs can deliver any type of molecular cargo including solid nanoparticles. Herein, this paper will discuss the classification of CPPs, the mechanism of cell entry, the application of CPPs in tumor therapy, and recent advances in targeted cell penetration that involve CPPs.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D057846 Cell-Penetrating Peptides Peptides that have the ability to enter cells by crossing the plasma membrane directly, or through uptake by the endocytotic pathway. Cell Penetrating Peptide,Cell-Penetrating Peptide,Peptides, Cell-Penetrating,Cell Penetrating Peptides,Penetrating Peptide, Cell,Peptide, Cell Penetrating,Peptide, Cell-Penetrating,Peptides, Cell Penetrating

Related Publications

Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
September 2012, Pharmaceuticals (Basel, Switzerland),
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
May 2015, Pharmaceutical research,
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
January 2015, Current cancer drug targets,
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
March 2017, Journal of controlled release : official journal of the Controlled Release Society,
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
December 2008, Biochimica et biophysica acta,
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
August 2007, Biochemical Society transactions,
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
January 2013, Frontiers in oncology,
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
March 2010, Pharmaceuticals (Basel, Switzerland),
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
January 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology,
Young Suk Choi, and Jue Yeon Lee, and Jin Sook Suh, and Seung Jin Lee, and Victor C Yang, and Chong Pyoung Chung, and Yoon Jeong Park
November 2021, Research square,
Copied contents to your clipboard!